Plus Therapeutics, Inc. (PSTV)
0.2599
+0.03
(+11.12%)
USD |
NASDAQ |
Feb 06, 16:00
0.2529
-0.01
(-2.69%)
After-Hours: 20:00
Plus Therapeutics EPS Diluted (Quarterly) : -0.0412 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.017 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1888 |
| Boston Scientific Corp. | 0.4493 |
| Apyx Medical Corp. | -0.0487 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.423M |
| Revenue (Quarterly) | 1.397M |
| Total Expenses (Quarterly) | 5.82M |
| Enterprise Value | 19.14M |
| Gross Profit Margin (Quarterly) | 93.84% |
| Profit Margin (Quarterly) | -316.6% |
| Earnings Yield | -732.7% |
| Normalized Earnings Yield | -571.99 |